π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This will be a randomized single-blind controlled trial to determine the im...
Status
Completed
Location
Hospital Ampang
Start Date
2022-09-20
Trial ID
NCT05517642
The 2019 novel-coronavirus (2019-nCov) is the cause of a cluster of unexpla...
Status
Completed
Location
Hubei Provincial Center for Disease Control and Prevention
Start Date
2020-03-16
Trial ID
NCT04313127
Treatments Being Tested
This study is a phase III clinical trial to evaluate efficacy, reactogenici...
Status
Completed
Location
Federal budgetary institution of science "Central Research Institute of Epidemiology" of the Federal Service for Surveillance on Consumer Rights Protectionand Human Welfare
Start Date
2020-09-11
Trial ID
NCT04540419
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled I/II clinical ...
Status
Completed
Location
Jiangsu Provincal Center for Disease Control and Prevention
Start Date
2021-04-21
Trial ID
NCT04840992
This is a phase II, randomised, double-blinded and placebo-controlled clini...
Status
Completed
Location
Hubei Provincial Center for Disease Control and Prevention
Start Date
2020-04-12
Trial ID
NCT04341389
Treatments Being Tested
Part 1: An open label, dose and age escalation phase to evaluate the safety...
Status
Terminated
Location
Ark Clinical Research
Start Date
2021-10-22
Trial ID
NCT05067933
Treatments Being Tested
This phase III clinical trial is an endpoint-driven randomized, double-blin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-15
Trial ID
NCT05124561
Treatments Being Tested
The purpose of this study: to assess the safety, tolerability and immunogen...
Status
Unknown
Location
Federal state budgetary institution "Central clinical hospital with polyclinic" Of the office Of the President of the Russian Federation
Start Date
2020-10-22
Trial ID
NCT04587219
Treatments Being Tested
This is a multicenter, parallel groups, partially randomized, open-label, b...
Status
Unknown
Location
Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2023-05-18
Trial ID
NCT05855408
This is a multicenter, open-label, partially radomized, parallel-controlled...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2022-01-22
Trial ID
NCT05204589
Treatments Being Tested